BAK
BAK
Braskem S.A.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $17.3B ▼ | $1.36B ▲ | $-26M ▲ | -0.15% ▲ | $-0.07 ▲ | $-1.02B ▼ |
| Q2-2025 | $17.86B ▼ | $1.32B ▲ | $-267M ▼ | -1.5% ▼ | $-0.66 ▼ | $2.36B ▼ |
| Q1-2025 | $19.46B ▲ | $1.21B ▼ | $698M ▲ | 3.59% ▲ | $1.76 ▲ | $3.26B ▲ |
| Q4-2024 | $19.15B ▼ | $1.45B ▲ | $-5.65B ▼ | -29.48% ▼ | $-14.18 ▼ | $-1.06B ▼ |
| Q3-2024 | $21.27B | $1.23B | $-593M | -2.79% | $-1.48 | $1.08B |
What's going well?
Net loss shrank dramatically, and gross profit improved despite lower sales. Interest expense fell, and there was a big tax benefit this quarter.
What's concerning?
Sales are dropping, expenses are rising, and the company is still losing money at the core business level. Results rely heavily on unusual gains, not real business strength.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $7.41B ▼ | $87.38B ▼ | $90.56B ▼ | $-3.53B ▲ |
| Q2-2025 | $10.3B ▼ | $91.3B ▼ | $94.56B ▼ | $-3.81B ▲ |
| Q1-2025 | $13.03B ▼ | $95.42B ▼ | $99.22B ▼ | $-4.24B ▲ |
| Q4-2024 | $16.77B ▲ | $101.58B ▲ | $105.85B ▲ | $-4.78B ▼ |
| Q3-2024 | $14.34B | $92.65B | $94.14B | $-25M |
What's financially strong about this company?
They have a large base of real assets, especially in property and equipment. Debt is mostly long-term, giving some breathing room, and inventory is moving rather than piling up.
What are the financial risks or weaknesses?
The company owes more than it owns, with negative equity and high debt levels. Cash reserves are falling, and there’s little cushion if business gets worse.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-26M ▲ | $-683M ▼ | $-1.06B ▼ | $-732M ▲ | $-2.52B ▼ | $-1.95B ▼ |
| Q2-2025 | $-267M ▼ | $-285M ▲ | $-696M ▼ | $-1.04B ▼ | $-2.13B ▲ | $-933M ▲ |
| Q1-2025 | $698M ▲ | $-2.33B ▼ | $-576M ▲ | $-191M ▼ | $-3.67B ▼ | $-2.98B ▼ |
| Q4-2024 | $-8.33B ▼ | $817M ▲ | $-1.02B ▼ | $2.39B ▲ | $3.07B ▲ | $-215M ▲ |
| Q3-2024 | $-1.31B | $-790M | $-629M | $-637M | $-2.29B | $-1.63B |
What's strong about this company's cash flow?
The company still has $6.66 billion in cash, and working capital changes helped soften the cash burn this quarter.
What are the cash flow concerns?
Cash burn is rising fast, with negative free cash flow of $1.95 billion and no sign of improvement. Cash reserves are dropping and could run out in under a year if trends continue.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Braskem S.A.'s financial evolution and strategic trajectory over the past five years.
Braskem benefits from large scale, an integrated production network, and entrenched positions in key chemical and plastics markets. It has shown resilience in keeping EBITDA positive despite a tough environment and has increased its cash reserves. Its innovation agenda—especially around bio-based polymers, recycling, and digital optimization—has given it a differentiated, sustainability-focused profile and strong relationships with major brand owners.
The main concerns are financial and cyclical. Profitability has collapsed from earlier highs to substantial losses, with margins under pressure across the board. The balance sheet now carries high and rising debt, negative equity, and deep accumulated losses, which heighten solvency and refinancing risk if conditions remain adverse. Weak and volatile operating and free cash flow, combined with ongoing capital needs, further limit room for error in execution and in macro conditions.
The near-term outlook is challenging: returning to consistent profitability and positive free cash flow will likely require both a more favorable industry cycle and internal improvements in cost control, asset utilization, and capital discipline. Over the longer term, Braskem’s leadership in sustainable materials and circular solutions could become a stronger earnings driver if customers and regulators continue to push for greener plastics. Overall, the company sits at a crossroads where strategic strengths and innovation potential are clear, but must be balanced against a currently stressed financial position and elevated uncertainty.
About Braskem S.A.
https://www.braskem.com.brBraskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $17.3B ▼ | $1.36B ▲ | $-26M ▲ | -0.15% ▲ | $-0.07 ▲ | $-1.02B ▼ |
| Q2-2025 | $17.86B ▼ | $1.32B ▲ | $-267M ▼ | -1.5% ▼ | $-0.66 ▼ | $2.36B ▼ |
| Q1-2025 | $19.46B ▲ | $1.21B ▼ | $698M ▲ | 3.59% ▲ | $1.76 ▲ | $3.26B ▲ |
| Q4-2024 | $19.15B ▼ | $1.45B ▲ | $-5.65B ▼ | -29.48% ▼ | $-14.18 ▼ | $-1.06B ▼ |
| Q3-2024 | $21.27B | $1.23B | $-593M | -2.79% | $-1.48 | $1.08B |
What's going well?
Net loss shrank dramatically, and gross profit improved despite lower sales. Interest expense fell, and there was a big tax benefit this quarter.
What's concerning?
Sales are dropping, expenses are rising, and the company is still losing money at the core business level. Results rely heavily on unusual gains, not real business strength.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $7.41B ▼ | $87.38B ▼ | $90.56B ▼ | $-3.53B ▲ |
| Q2-2025 | $10.3B ▼ | $91.3B ▼ | $94.56B ▼ | $-3.81B ▲ |
| Q1-2025 | $13.03B ▼ | $95.42B ▼ | $99.22B ▼ | $-4.24B ▲ |
| Q4-2024 | $16.77B ▲ | $101.58B ▲ | $105.85B ▲ | $-4.78B ▼ |
| Q3-2024 | $14.34B | $92.65B | $94.14B | $-25M |
What's financially strong about this company?
They have a large base of real assets, especially in property and equipment. Debt is mostly long-term, giving some breathing room, and inventory is moving rather than piling up.
What are the financial risks or weaknesses?
The company owes more than it owns, with negative equity and high debt levels. Cash reserves are falling, and there’s little cushion if business gets worse.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-26M ▲ | $-683M ▼ | $-1.06B ▼ | $-732M ▲ | $-2.52B ▼ | $-1.95B ▼ |
| Q2-2025 | $-267M ▼ | $-285M ▲ | $-696M ▼ | $-1.04B ▼ | $-2.13B ▲ | $-933M ▲ |
| Q1-2025 | $698M ▲ | $-2.33B ▼ | $-576M ▲ | $-191M ▼ | $-3.67B ▼ | $-2.98B ▼ |
| Q4-2024 | $-8.33B ▼ | $817M ▲ | $-1.02B ▼ | $2.39B ▲ | $3.07B ▲ | $-215M ▲ |
| Q3-2024 | $-1.31B | $-790M | $-629M | $-637M | $-2.29B | $-1.63B |
What's strong about this company's cash flow?
The company still has $6.66 billion in cash, and working capital changes helped soften the cash burn this quarter.
What are the cash flow concerns?
Cash burn is rising fast, with negative free cash flow of $1.95 billion and no sign of improvement. Cash reserves are dropping and could run out in under a year if trends continue.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Braskem S.A.'s financial evolution and strategic trajectory over the past five years.
Braskem benefits from large scale, an integrated production network, and entrenched positions in key chemical and plastics markets. It has shown resilience in keeping EBITDA positive despite a tough environment and has increased its cash reserves. Its innovation agenda—especially around bio-based polymers, recycling, and digital optimization—has given it a differentiated, sustainability-focused profile and strong relationships with major brand owners.
The main concerns are financial and cyclical. Profitability has collapsed from earlier highs to substantial losses, with margins under pressure across the board. The balance sheet now carries high and rising debt, negative equity, and deep accumulated losses, which heighten solvency and refinancing risk if conditions remain adverse. Weak and volatile operating and free cash flow, combined with ongoing capital needs, further limit room for error in execution and in macro conditions.
The near-term outlook is challenging: returning to consistent profitability and positive free cash flow will likely require both a more favorable industry cycle and internal improvements in cost control, asset utilization, and capital discipline. Over the longer term, Braskem’s leadership in sustainable materials and circular solutions could become a stronger earnings driver if customers and regulators continue to push for greener plastics. Overall, the company sits at a crossroads where strategic strengths and innovation potential are clear, but must be balanced against a currently stressed financial position and elevated uncertainty.

CEO
Roberto Prisco Paraíso Ramos
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-05-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 11
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
UBS GROUP AG
Shares:783.45K
Value:$3M
VANGUARD GROUP INC
Shares:560.47K
Value:$2.15M
RUSSELL FRANK CO/
Shares:379.3K
Value:$1.45M
Summary
Showing Top 3 of 84

